MDS Nordion Schedule 13A

SC 13D/A 1 nordion_13d42-foodtechnology.htm NORDION'S OWNERSHP IN FTSI MDS Nordion Schedule 13A SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

SCHEDULE 13D

Under Securities Exchange Act of 1934

(Amendment No. 42)

Food Technology Service, Inc.
(formerly Vindicator, Inc.)
-------------------------------------------------------------------------------------------------
(Name of Issuer)

Common Shares, $0.01 Par Value
--------------------------------------------------------------------------------------------------
(Title of Class of Securities)

344798103
--------------------------------------------------------------------------------------------------
(CUSIP Number)

David L. Nicholds, Esq.
MDS Nordion, a division of MDS (Canada) Inc.
(a successor of MDS Nordion Inc.) ("MDS Nordion")
447 March Road
Ottawa, Ontario, Canada K2K 1X8
--------------------------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

Subject to completion of documentation November 15, 2004

--------------------------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13D to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ]

Check the following box if a fee is being paid with the statement [ ]. (A fee is not required only if the reporting person: (1) has a pervious statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.)

Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent.

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 13 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP NO. 344798103

PAGE 1 OF 5 PAGES

1	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON. MDS Nordion ___________________________________________________________________________________
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*. (a) [ ] (b) [ ] ____________________________________________________________________________________
3	SEC USE ONLY ____________________________________________________________________________________
4	SOURCE OF FUNDS* WC & Affiliate ____________________________________________________________________________________
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e). [ ] ____________________________________________________________________________________
6	CITIZENSHIP OR PLACE OF ORGANIZATION. Ontario, Canada ____________________________________________________________________________________
Number of Shares Beneficially Owned by each Reporting Person with	7	Sole Voting Power: ____________________________________________________________________________
	8	Shared Voting Power: 4,460,540 ____________________________________________________________________________
	9	Sole Dispositive Power: ____________________________________________________________________________
	10	Shared Dispositive Power: 4,460,540 ____________________________________________________________________________
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON. 4,460,540 ____________________________________________________________________________________
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] ____________________________________________________________________________________
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 37.49% ____________________________________________________________________________________
14	TYPE OF REPORTING PERSON* CO ____________________________________________________________________________________

*SEE INSTRUCTIONS BEFORE FILLING OUT!

SCHEDULE 13D

CUSIP NO. 344798103

PAGE 2 OF 5 PAGES

1	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON. Laboratoires MDS Quebec Ltée ______________________________________________________________________________________________________
2	*CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP. (a) [ ]** (b) [ ] ____________________________________________________________________________________
3	SEC USE ONLY ____________________________________________________________________________________
4	SOURCE OF FUNDS* Affiliate ____________________________________________________________________________________
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e). [ ] ____________________________________________________________________________________
6	CITIZENSHIP OR PLACE OF ORGANIZATION. Quebec, Canada ____________________________________________________________________________________
Number of Shares Beneficially Owned by each Reporting Person with	7	Sole Voting Power: ____________________________________________________________________________
	8	Shared Voting Power: 4,460,540 ____________________________________________________________________________
	9	Sole Dispositive Power: ____________________________________________________________________________
	10	Shared Dispositive Power: 4,460,540 ____________________________________________________________________________
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON. 4,460,540 ____________________________________________________________________________________
12	*CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ____________________________________________________________________________________**
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 37.49% ____________________________________________________________________________________
14	TYPE OF REPORTING PERSON* CO ____________________________________________________________________________________

*SEE INSTRUCTIONS BEFORE FILLING OUT!

SCHEDULE 13D

CUSIP NO. 344798103

PAGE 3 OF 5 PAGES

1	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON. MDS INC. ____________________________________________________________________________________
2	*CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP. (a) [ ]** (b) [ ] ____________________________________________________________________________________
3	SEC USE ONLY
4	SOURCE OF FUNDS* WC & Affiliate ____________________________________________________________________________________
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e). [ ] ____________________________________________________________________________________
6	CITIZENSHIP OR PLACE OF ORGANIZATION. Ontario, Canada ____________________________________________________________________________________
Number of Shares Beneficially Owned by each Reporting Person with	7	Sole Voting Power: ____________________________________________________________________________
	8	Shared Voting Power: 4,460,540 ____________________________________________________________________________
	9	Sole Dispositive Power: ____________________________________________________________________________
	10	Shared Dispositive Power: 4,460,540 ____________________________________________________________________________
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON. 4,460,540 ____________________________________________________________________________________
12	*CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]** ____________________________________________________________________________________
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 37.49% ___________________________________________________________________________________
14	TYPE OF REPORTING PERSON* CO ____________________________________________________________________________________

*SEE INSTRUCTIONS BEFORE FILLING OUT!

Item 1.	Security and Issuer Shares of Common Stock, $0.01 par value Food Technology Service, Inc. 502 Prairie Mine Road Mulberry, Florida 33860 USA ________________________________________________________________________________________________
Item 2.	Identity and Background N/A ________________________________________________________________________________________
Item 3.	Source and Amount of Funds or Other Consideration. N/A ________________________________________________________________________________________
Item 4.	Purpose of Transaction Item 4 is hereby amended. As at November 15, 2004, Food Technology Service, Inc. ("FTSI") paid down $100,000US of its indebtedness to MDS Nordion. FTSI current indebtedness to MDS Nordion is $563,194US and is convertible to stock ("Convertible Indebtedness"). The Convertible Indebtedness is convertible into common shares of FTSI at the conversion rate of 70% of the closing price on the last trade date prior to the date of exercise of the conversion right. Since the 13D Amendment 41, filed with the SEC in August, 2004, (which calculated the beneficially owned shares based on the closing share price on August 9, 2004 i.e., 70% of $1.04 or $0.728) the closing share price of FTSI decreased to $0.90 as of November 12, 2004 . The conversion price therefore on November 15, 2004 was $0.630 (70% of $0.90). At the close of business on November 15, 2004, Nordion beneficially owned 4,460,540 shares of stock, which constitutes approximately 37.49% of the outstanding shares of FTSI. The number of shares beneficially owned as of November 15, 2004 has been computed by aggregating (i) the number of shares that Nordion actually owned minus 170,000 shares sold by private sale by MDS Nordion effective November 15, 2004; and (ii) the number of shares into which Nordion could elect to convert the Convertible Indebtedness on the basis of the closing price on November 12, 2004 (i.e., 70% of $0.90) or 893,958 shares. Pursuant to publicly available information 11,001,038 shares of Food Technology Service, Inc. were issued and outstanding as of November 15, 2004. ________________________________________________________________________________________
Item 5.	Interest in Securities of the Issuer See Item 4 and 6. ________________________________________________________________________________________
Item 6.	Contracts, Arrangements, Understanding or Relationships with Respect to Securities of the Issuer. By Letter Agreement dated December 5, 2003, MDS Nordion extended its waiver of right of conversion of interest accruing on FTSI Convertible Indebtedness to January 1, 2005. By Letter Agreement entered into on June 9, 2004 and effective May 1, 2004, MDS Nordion (an affiliated reporting person) granted to Colorado Boxed Beef Company (a non-affiliated person) the right to purchase from MDS Nordion, up to 250,000 restricted shares of stock of FTSI at $0.95 per share, exercisable within the following one month period, which period, by letter dated June 9, 2004, was extended to September 15, 2004. As of June 9, 2004, Colorado Boxed Beef exercised its right to purchase 150,000 of such restricted shares in FTSI (previously reported) leaving a balance of 100,000 restricted shares, subject to such right to purchase. In addition, MDS Nordion granted to Colorado Boxed Beef Company the right, subject to certain performance conditions, to purchase up to 250,000 additional restricted shares of the stock of FTSI from MDS Nordion at $1.10 per share, exercisable until May 1, 2006, which right may be cancelled by MDS Nordion at anytime on one months notice. In the event that the shares of FTSI are subdivided or consolidated, the shares of FTSI to be transferred pursuant to this Letter Agreement will be concurrently adjusted in the same proportion and in the same manner. Colorado Boxed Beef Company has agreed that any shares acquired pursuant to these options will not be sold in such volume that their sales exceed 50% of the shares of FTSI publicly traded in any given week. By private sale, effective November 15, 2004, MDS Nordion sold 170,000 shares of FTSI. ________________________________________________________________________________________
Item 7.	Materials to be filed as Exhibits N/A ________________________________________________________________________________________

SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief the undersigned certify that the information set forth in this statement is true and correct.

Dated: November 22, 2004

MDS NORDION, a division of MDS (Canada) Inc.

By: /s David L. Nicholds
Name:  David Nicholds
Title: Vice President, General Counsel
             & Corporate Secretary

MDS INC.

By: /s/ Peter E. Brent

Name: Peter E. Brent
Title: Senior Vice President & General Counsel
              & Corporate Secretary

LABORATOIRES MDS QUEBEC LTEE.

By: /s/ Peter E. Brent

Name: Peter E. Brent
Title: Vice President & Corporate Secretary